SS
ELDN icon

Sunbelt Securities’s Eledon Pharmaceuticals ELDN Stock Holding History

Sunbelt Securities’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80 Buy
+26
New +$61 ﹤0.01% 2699

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Sunbelt Securities's ELDN Position: Q1 2026 in Review

Sunbelt Securities opened a new position in Eledon Pharmaceuticals (ELDN) in Q1 2026: 26 shares worth $80. The stake represents ﹤0.01% of the portfolio and ranks #2699 among its holdings.

121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Sunbelt Securities held 26 shares of Eledon Pharmaceuticals worth $80 as of Q1 2026.
  • Eledon Pharmaceuticals was a new Sunbelt Securities position in Q1 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2699 holding.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.